6c2c9baa Dd0d 4380 8cdf F6b4d542e079 01
Tenofovir Disoproxil Fumarate Tablet
Product Images NDC 69097-533
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Tenofovir Disoproxil Fumarate (NDC 69097-533). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
6c2c9baa Dd0d 4380 8cdf F6b4d542e079 02
Each tablet contains Tenofovir Isoproxil Fumarate 500mg equivalent to 245mg of Tenofovir Disoproxil. The tablets are film-coated and are available only on prescription. It is recommended to refer to the package insert for dosages and administration. The tablets should be stored in a closed container at 20°C to 25°C or 68°F to 77°F. The tablets are manufactured by Cipla Ltd. in Verna, Goa, India, and distributed by Cipla USA, Inc. in Warren, NJ. The details for batch information printing can be found in a designated area of the packet.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
